| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |